Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 17% in First Half of 2023

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 1.2 billion yuan in the first half of 2023, up 17% year-on-year.

Meanwhile, the company posted 3.9 billion yuan in revenue, up 18.4% year-on-year.

At the end of the reporting period, it had 32.2 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 5.5%.